GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1%
Wed, 24 Jul

GSK PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:

GSK PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Jun-18*
3
Mar-19*
3
Jun-19*
QoQ ChangeYoY Change
Net SalesRs m7,3577,5127,8804.9%7.1%
Other incomeRs m178525305-41.8%71.8%
TurnoverRs m7,5348,0378,1861.9%8.6%
ExpensesRs m5,9535,8766,2255.9%4.6%
Gross profitRs m1,3211,6051,6553.1%25.3%
DepreciationRs m11413719139.3%67.8%
InterestRs m2191062.5%365.0%
Profit before taxRs m1,3831,9921,760-11.6%27.3%
TaxRs m497761626-17.8%25.8%
Profit after taxRs m8861,2301,135-7.8%28.1%
Gross profit margin%18.021.421.0
Effective tax rate%35.938.235.5
Net profit margin%11.815.313.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 7.1% on a year-on-year (YoY) basis. The expenses were up by 4.6% YoY during the same period.
  • The company's operating profit increased by 25.3% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 21.0% in 1QFY20 as against 18.0% in 1QFY19.
  • Depreciation charges increased by 67.8% and finance costs increased by 365.0% YoY, respectively.
  • Other income increased by 71.8% YoY during the quarter.
  • Net profit for the quarter increased by 28.1% YoY. Net profit margins during the quarter increased from 11.8% in 1QFY19 to 13.9% in 1QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 4.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 5.9% QoQ during the same period.
  • The company's operating profit declined by 3.1% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 21.0% in 1QFY20 as against 21.4% in 4QFY19.
  • Net profit for the quarter declined by 7.8% QoQ, while net profit margins declined from 15.3% in 4QFY19 to 13.9% in 1QFY20.

To see how GSK PHARMA has performed over the last eight quarters,please visit here.

GSK PHARMA Share Price Performance

Over the last one year,GSK PHARMA share price has moved down from Rs 1,575.5 to Rs 1,194.0, registering a Loss of Rs 381.5 or around 24.2%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,719.6 (down 0.5%). Over the last one year it has moved down from 13,961.0 to 12,719.6, a gain of 1,241 points (down 8.9%).

Overall, the S&P BSE SENSEX is up 3.2% over the year.

Current Valuations

At the current price of Rs 1,194.0, the price to earnings (P/E) ratio of GSK PHARMA stands at 44.9 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 9.5 times.

Equitymaster requests your view! Post a comment on "GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1%". Click here!

  

Related Views on News

GSK PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 24, 2019 | Updated on Jun 24, 2019

Here's an analysis of the annual report of GSK PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of GSK PHARMA. Also includes updates on the valuation of GSK PHARMA.

GSK PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 16.6% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 16.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 26.0% (Quarterly Result Update)

Feb 5, 2019 | Updated on Feb 5, 2019

For the quarter ended December 2018, GSK PHARMA has posted a net profit of Rs 1 bn (up 26.0% YoY). Sales on the other hand came in at Rs 8 bn (up 17.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

What if Indiabulls Housing Finance and Yes Bank Do Not Rebound?(Profit Hunter)

Oct 1, 2019

How long should you wait for fallen blue chips like Yes Bank and Indiabulls Housing Finance to rebound?

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Oct 14, 2019 (Close)

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - MYLAN COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS